Planned Transition to Sirolimus-Based Therapy Versus Continued Tacrolimus-Based Therapy in Renal Allograft Recipients.
Phase of Trial: Phase IV
Latest Information Update: 04 Nov 2014
At a glance
- Drugs Sirolimus (Primary) ; Tacrolimus
- Indications Renal transplant rejection
- Focus Therapeutic Use
- Sponsors Pfizer
- 08 Nov 2013 Top-line results reported in a Pfizer media release.
- 08 Nov 2013 Status changed from recruiting to completed, as reported by a Pfizer media release.
- 08 Nov 2013 Primary endpoint 'significant difference in percentage of patients with an improvement in glomerular filtration rate over 24 months' has not been met, as reported by a Pfizer media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History